We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
T. Rowe Price
TROW
$24.6B
| $93.6M | 0.3% |
1,117,321
-11,284
| -1% | -$883K |
|
52
Broadridge
BR
$16.7B
| $90M | 0.29% |
2,276,327
+76,476
| +3% | +$2.76M |
|
53
Regions Financial
RF
$26.2B
| $89.6M | 0.29% |
9,060,901
+391,723
| +5% | +$3.77M |
|
54
Lowe's Companies
LOW
$113B
| $83.1M | 0.27% |
1,677,760
+9,051
| +0.5% | +$440K |
|
|
CLGX
55
DELISTED
Corelogic, Inc.
CLGX
| $82.8M | 0.27% |
2,330,996
+80,394
| +4% | +$2.61M |
|
|
ININ
56
DELISTED
Interactive Intelligence Group, inc.
ININ
| $82.4M | 0.27% |
1,222,890
-8,416
| -0.7% | -$539K |
|
57
GE Aerospace
GE
$362B
| $81.5M | 0.26% |
606,346
+6,910
| +1% | +$870K |
|
58
American Express
AXP
$233B
| $78.9M | 0.26% |
869,314
+10,129
| +1% | +$832K |
|
59
TJX Companies
TJX
$170B
| $78.3M | 0.25% |
2,457,460
+41,178
| +2% | +$1.25M |
|
60
Novartis
NVS
$297B
| $76.7M | 0.25% |
1,065,378
+36,356
| +4% | +$2.53M |
|
61
M&T Bank
MTB
$35.6B
| $76.7M | 0.25% |
658,806
+31,928
| +5% | +$3.63M |
|
62
Elevance Health
ELV
$82.3B
| $75.6M | 0.25% |
818,702
-72,197
| -8% | -$6.42M |
|
63
iShares Core S&P 500 ETF
IVV
$875B
| $72.2M | 0.23% |
389,112
-17,314
| -4% | -$3.08M |
|
64
Pfizer
PFE
$143B
| $71.9M | 0.23% |
2,473,687
-14,727
| -0.6% | -$429K |
|
|
STI
65
DELISTED
SunTrust Banks, Inc.
STI
| $68.7M | 0.22% |
1,867,175
+130,251
| +7% | +$4.54M |
|
66
Cisco
CSCO
$444B
| $67.8M | 0.22% |
3,024,063
+961,921
| +47% | +$21.3M |
|
67
PepsiCo
PEP
$184B
| $67.3M | 0.22% |
811,124
-81,969
| -9% | -$6.81M |
|
|
DGI
68
DELISTED
DigitalGlobe Inc.
DGI
| $65.6M | 0.21% |
1,592,992
+307,368
| +24% | +$11.1M |
|
69
Edwards Lifesciences
EW
$48.3B
| $64M | 0.21% |
5,840,502
+4,640,664
| +387% | +$52.3M |
|
70
Procter & Gamble
PG
$342B
| $63.4M | 0.21% |
779,023
-8,660
| -1% | -$706K |
|
|
AWAY
71
DELISTED
HOMEAWAY INC COM
AWAY
| $61M | 0.2% |
1,493,020
+80,675
| +6% | +$2.75M |
|
72
Rogers Communications
RCI
$17.6B
| $60.6M | 0.2% |
1,339,994
+37,649
| +3% | +$1.68M |
|
73
Oracle
ORCL
$346B
| $59.8M | 0.19% |
1,563,215
+124,503
| +9% | +$4.28M |
|
|
WCN
74
Waste Connections
WCN
$42.7B
| $58.8M | 0.19% |
2,020,827
+72,577
| +4% | +$2.12M |
|
75
Owens Corning
OC
$11.2B
| $58.8M | 0.19% |
1,443,323
+12,644
| +0.9% | +$480K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.